Subfoveal choroidal neovascularization of various macular diseases is one of the causes of severe blindness, including age-related macular degeneration (AMD). Several environmental risk factors have been elucidated in the pathogenesis of AMD, including smoking, 1 atherosclerosis, 2 increased levels of plasma fibrinogen, 3 and low levels of antioxidant vitamins. 4 Recent observations support the hypothesis that antioxidant and/or vitamin treatment may delay progression of AMD and vision loss. 5 However, the exact cause of AMD remains to be determined.
Recently, Ikeda et al 6 showed that increased plasma oxidized lowdensity lipoprotein (oxLDL) levels may be involved in the pathogenesis of AMD. Oxidized LDL has been implicated as having a major role in atherosclerosis, and many of the pathologic and biochemical features seen in choroidal neovascularization are analogous to those seen in advanced atherosclerosis, such as the infiltration of monocytes and macrophages and the overexpression of adhesion molecules, monocyte chemotactic proteins, growth factors, and cytokines within lesions. 7, 8 Lectinlike oxidized lowdensity lipoprotein receptor type 1 (LOX-1) is a recently identified ox-LDL receptor that is abundantly expressed in vascular endothelial cells. 9 Its messenger RNA has been shown to be expressed in atheromatous lesions, 9 and LOX-1 up-regulation has been observed in several vascular lesions, including hypertensive remodeling lesions, diabetic vascular lesions, and macrophages. 10 The observation of LOX-1 up-regulation in vascular lesions, the potential roles of oxLDL in the pathogenesis of AMD, and the possible similarity between the pathogenesis of atherosclerosis and that of AMD prompted us to examine LOX-1 expression in choroidal neovascularization. In addition, we sought to measure plasma cholesterol levels to investigate the relationship between LOX-1 expression and hyperlipidemia.
We examined LOX-1 localization in 13 surgically excised neovascular membranes, including 10 from patients with AMD, 1 from a patient with idiopathic choroidal neovascularization, and 2 from patients with myopic choroidal neovascularization. The membranes were frozen in liquid nitrogen within 30 minutes of excision. Multiple 8-µm cryosections from each membrane were air-dried, fixed in acetone for 5 minutes, washed with phosphate-buffered saline, and blocked for 30 minutes with 2% bovine serum albumin in phosphatebuffered saline. They were then incubated with primary antibody and washed 3 times for 5 minutes with 
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We did not find LOX-1 within the posterior segment of normal eyes, including the choriocapillaries (Table) . As is further summarized in the Table, greater LOX-1 staining was found in the membranes of the patients with AMD compared with those with idiopathic or myopic choroidal neovascularization, those with a relatively high plasma total cholesterol level, and those of patients with larger macular serous detachment.
Our findings suggest that LOX-1 plays an active role in the pathogenesis of choroidal neovascularization, especially in AMD. However, further experiments are needed to determine whether LOX-1 plays a role in mediating the processes in AMD that are compatible with those in atherosclerosis.
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Histopathology of Documented Growth in Small Melanocytic Choroidal Tumors
Differentiation of a choroidal nevus from a small choroidal melanoma can be difficult. Choroidal nevi are generally asymptomatic lesions 1 that are less than 6 mm in diameter and less than 1.5 mm in height. The presence of drusen or areas of atrophy of the overlying retinal pigment epithelium generally indicate a chronic, inactive choroidal nevus.
1 Orange pigment and subretinal fluid are more commonly present in choroidal melanomas. 2 Echography usually demonstrates medium to high internal reflectivity in nevi and low reflectivity in melanomas. Documented growth 3, 4 is widely interpreted as evidence of malignancy.
We provide the histopathology of 2 small choroidal melanocytic tumors that became symptomatic, developed orange pigment, and showed documented growth. One lesion was an epithelioid malignant melanoma; the other was a benign nevus.
Report of Cases. Case 1.
A 45-yearold man was examined in May 1996 at the Ocular Oncology Clinic of the University of Michigan Kellogg Eye Center, Ann Arbor, for an enlarging, small juxtapapillary choroidal lesion in his right eye. A photograph from 1994 (Figure 1) showed a flat, brown 3.0ϫ1.8-mm choroidal lesion, superior to the disc, without drusen or orange pigment. The lesion had increased to 3.0ϫ3.0 mm and developed extensive orange pigment over its surface. Echography revealed a maximal height of 1.5 mm with a medium internal acoustic pattern. The initial diagnosis was a probable melanoma, but a decision was made to observe for evidence of continued growth before initiating therapy. In July 1996, the patient complained of blurred vision in his right eye. Results of an examination showed that the base had further increased to 3.3 ϫ 3.2 mm (Figure 2) . Repeat echography revealed that tumor height had 
